Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Dermatology

Free Subscription 11.08.2025 4 Am J Dermatopathol 2 BMC Cancer 1 Cancer 2 Clin Exp Dermatol 5 Cutis 10 Int J Dermatol 2 Intern Med 5 J Cutan Pathol 7 J Dermatol 7 J Invest Dermatol 1 Lancet 2 N Engl J Med 6 PLoS One 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Dermatopathol

1. ZOU Y, Li L, Xia R, Wang F, et al
   Accuracy of Confocal Microscopy for the Diagnosis of Acral Lentiginous Melanoma and Acral Melanocytic Nevi.
   Am J Dermatopathol. 2025 Aug 6. doi: 10.1097/DAD.0000000000003099.
   PubMed         Abstract available
   
   
2. ADDO AK, Beydoun HM, Jeyakumar JE, Olivares S, et al
   The Morphologic Spectrum of NF Mutated Desmoplastic Melanocytic Neoplasms.
   Am J Dermatopathol. 2025 Aug 6. doi: 10.1097/DAD.0000000000003056.
   PubMed         Abstract available
   
   
3. RINCK JA, Boothby-Shoemaker W, Friedman BJ
   Solitary Cutaneous Xanthogranuloma With DNMT3A Mutation Arising Postallogenic Transplant in a Patient With T-Cell Acute Lymphoblastic Leukemia.
   Am J Dermatopathol. 2025 Aug 5. doi: 10.1097/DAD.0000000000003095.
   PubMed         Abstract available
   
   
4. NG TTW, Hillan AL, Ghodsian MM, Ardakani NM, et al
   Acute Kava (Piper Methysticum) Dermatitis With Drug Reaction With Eosinophilia and Systemic Symptoms-Like Features and Sebotropic Inflammation: A Case Series.
   Am J Dermatopathol. 2025 Aug 4. doi: 10.1097/DAD.0000000000003084.
   PubMed         Abstract available
   
   

   
   BMC Cancer

5. SAROOSH R, Ahmad N, Israr B, Nazir A, et al
   Association of diabetes mellitus and breast cancer in adult men and women: a cross-sectional survey.
   BMC Cancer. 2025;25:1276.
   PubMed         Abstract available
   
   
6. AL-MASRI M, Aljalabneh B, AlMasri R, Alayyan O, et al
   Comparative survival analysis of HER2-positive Pregnancy-Associated Breast Cancer (PABC) and non-Pregnancy-Associated breast Cancer (non-PABC) cohorts: a matched control study.
   BMC Cancer. 2025;25:1252.
   PubMed         Abstract available
   
   

   
   Cancer

7. MILHEM MM, Zakharia Y, Davar D, Buchbinder EI, et al
   Intratumoral vidutolimod as monotherapy or in combination with pembrolizumab in patients with programmed cell death 1 blockade-resistant melanoma: Final analysis from a phase 1b study.
   Cancer. 2025;131:e70022.
   PubMed         Abstract available
   
   

   
   Clin Exp Dermatol

8. VARADHARAJAN A, Palaniappan V, Gopinath H, Karthikeyan K, et al
   Cutaneous Manifestations of Scrub Typhus: A Comprehensive Review of Diagnostic Clues in a Neglected Tropical Disease.
   Clin Exp Dermatol. 2025 Aug 5:llaf356. doi: 10.1093.
   PubMed         Abstract available
   
   
9. BUJAN BONINO C, Canovas Seva C, Suarez Penaranda JM, Florez A, et al
   Autonomic denervation dermatitis: reviewing ADDitional triggers besides total knee arthroplasty.
   Clin Exp Dermatol. 2025 Aug 2:llaf360. doi: 10.1093.
   PubMed        
   
   

   
   Cutis

10. SMAHA K, Willett M, Herold M, Kent DE, et al
    Managing Seromas Following Skin Graft Placement in Dermatologic Surgery.
    Cutis. 2025;115:202-203.
    PubMed         Abstract available
    
    
11. AFLATOONI S, Bair C, Coughlin E, Lipman Z, et al
    Comparing the Quality of Patient Guidance on Dermatologic Care Generated by ChatGPT vs Reddit.
    Cutis. 2025;115:197-199.
    PubMed         Abstract available
    
    
12. WILLIAMS PH, Momin F, Ellison E, Ahatov R, et al
    Recommendations for Empiric Antibiotic Therapy in Hidradenitis Suppurativa.
    Cutis. 2025;115:194-196.
    PubMed         Abstract available
    
    
13. SCOTT E, Burkhart CG, Elston DM
    Immune Responses and Health Disparities Warrant Scabies Vaccine Development.
    Cutis. 2025;115:181-186.
    PubMed         Abstract available
    
    
14. WIMBERLEY M, Nanda S, Papac N, Collins L, et al
    Enhancing Patient Satisfaction and Quality of Life With Mohs Micrographic Surgery: A Systematic Review of Patient Education, Communication, and Anxiety Management.
    Cutis. 2025;115:E11-E16.
    PubMed         Abstract available
    
    

    
    Int J Dermatol

15. ISAACS T, Jacobs T, Whitaker D, Visser W, et al
    Sun Protection Advice for the South African Population for the Prevention and Management of Skin Diseases.
    Int J Dermatol. 2025 Aug 4. doi: 10.1111/ijd.17994.
    PubMed         Abstract available
    
    
16. BELLOMO D, Gross C, Pazhava A, Perniciaro C, et al
    Flawed Benchmarks and Biased Cohorts: Reassessing the Evidence for CP-GEP (Merlin) Versus 31-GEP (DecisionDx-Melanoma).
    Int J Dermatol. 2025 Aug 5. doi: 10.1111/ijd.70000.
    PubMed        
    
    
17. CHERNYSHOV PV, Finlay AY, Tomas-Aragones L, Poot F, et al
    Quality-of-Life Measurement in Epidermolysis Bullosa. Position Statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient-Oriented Outcomes and External Experts.
    Int J Dermatol. 2025;64:1546-1557.
    PubMed         Abstract available
    
    
18. VON DANNECKER R, de Oliveira LML, Lapenda I, Pinto L, et al
    Clinical Outcomes and Prognosis in Atypical Fibroxanthoma: A Systematic Review and Meta-Analysis.
    Int J Dermatol. 2025;64:1592-1598.
    PubMed         Abstract available
    
    
19. DE NICOLAS-RUANES B, Fernandez-Lozano C, Gutierrez-Canales P, Ballester-Martinez A, et al
    Lymphocyte Transformation Tests and Patch Tests to Identify Drugs Potentially Associated With Bullous Pemphigoid Development.
    Int J Dermatol. 2025;64:1636-1643.
    PubMed         Abstract available
    
    
20. NAHM WJ, Sohail N, Burshtein J, Goldust M, et al
    Artificial Intelligence in Dermatology: A Comprehensive Review of Approved Applications, Clinical Implementation, and Future Directions.
    Int J Dermatol. 2025;64:1568-1583.
    PubMed         Abstract available
    
    
21. MUNOZ-BARBA D, Haselgruber de Francisco S, Leon-Perez FJ, Cuenca-Barrales C, et al
    Severity and Therapeutic Decisions Based on Lesion Location in Patients With Hidradenitis Suppurativa.
    Int J Dermatol. 2025;64:1607-1614.
    PubMed         Abstract available
    
    
22. KARPOFF K, Sun L, Cain CL, Valentine B, et al
    Paws to Patients: Canine Pyoderma Gangrenosum as a Reflective Model of Human Pyoderma Gangrenosum.
    Int J Dermatol. 2025;64:1584-1591.
    PubMed         Abstract available
    
    
23. DEMIREL OGUT N, Ilikci Sagkan R, Arici R, Gokyayla E, et al
    Serum C-Reactive Protein as a Potential Indicator for Screening Fecal Calprotectin in Patients With Moderate-to-Severe Hidradenitis Suppurativa: A Cross-Sectional Cohort Study.
    Int J Dermatol. 2025;64:1615-1622.
    PubMed         Abstract available
    
    
24. ARMARIO-HITA JC, Pereyra-Rodriguez JJ, de Ortiz de Frutos FJ, Herranz P, et al
    Clinical Characteristics, Diagnostic Approaches, Therapeutic Management, and Associated Comorbidities of Prurigo Nodularis (Chronic Nodular Prurigo): An Observational Study in Clinical Practice in Spain.
    Int J Dermatol. 2025;64:1623-1631.
    PubMed         Abstract available
    
    

    
    Intern Med

25. KAWANO H, Otsuka M, Umeda M, Uchida T, et al
    Loeffler Endocarditis with Antineutrophil Cytoplasmic Antibody-associated Vasculitis after COVID-19 Vaccination.
    Intern Med. 2025;64:2332-2337.
    PubMed         Abstract available
    
    
26. SUGIMOTO H, Sawa N, Oba Y, Kurihara S, et al
    A Rare Case of Goodpasture's Syndrome Combined with Polyarteritis Nodosa.
    Intern Med. 2025 Feb 1. doi: 10.2169/internalmedicine.4460.
    PubMed         Abstract available
    
    

    
    J Cutan Pathol

27. RUBIN AI, Shea CR, Ruben BS, Chan MP, et al
    Setting A New Standard for Histopathologic Reporting of Primary Cutaneous Melanoma: Progress Made by the Melanoma Reporting Task Force of the American Society of Dermatopathology.
    J Cutan Pathol. 2025 Aug 4. doi: 10.1111/cup.14836.
    PubMed        
    
    
28. ALNAQSHABANDI SM, Sharma A, Bakhshwin A, Ronen S, et al
    Subungual Epidermoid Inclusions-A Series of 8 Cases and a Review of Literature.
    J Cutan Pathol. 2025;52:574-579.
    PubMed         Abstract available
    
    
29. ZHU MY, Zhang L, Khazaeli M
    Review of Literature to Determine Recommended Application of HPV-42 Molecular Testing for Digital Papillary Adenocarcinoma.
    J Cutan Pathol. 2025;52:590-594.
    PubMed         Abstract available
    
    
30. SANCHEZ AC, Shiyanbola OO, Qian X, Yan D, et al
    Metastatic Gastrointestinal Stromal Tumor to the Scalp: A Case Report Highlighting Diagnostic Challenges and Molecular Correlation.
    J Cutan Pathol. 2025;52:549-553.
    PubMed         Abstract available
    
    
31. GARBANZOS CCT, Todd A, Hardway HD, Lehman JS, et al
    Clinical, Serologic, and Histopathologic Features of Patients With Pemphigus With Either Positive or Negative IgG4 Intercellular Deposition by Direct Immunofluorescence (DIF): A Retrospective Case-Control Study of 55 DIF Biopsy Specimens.
    J Cutan Pathol. 2025;52:580-589.
    PubMed         Abstract available
    
    

    
    J Dermatol

32. KAKURAI M, Akashi T, Moriyama Y
    Spontaneous Regression of Cutaneous Angiosarcoma: A Case Report.
    J Dermatol. 2025 Aug 8. doi: 10.1111/1346-8138.17903.
    PubMed        
    
    
33. HANAMI Y, Nakamura T, Irie K, Mishima H, et al
    Familial Cases of Aicardi-Goutieres Syndrome Presenting With Cutaneous Manifestations of Facial Lipodystrophy and Puffy Digits.
    J Dermatol. 2025 Aug 7. doi: 10.1111/1346-8138.17898.
    PubMed        
    
    
34. KASHANI AN, Yazdanparast T, Amiri F, Kashani MN, et al
    Biophysical and Ultrasonographic Findings of Cutaneous Macular Amyloidosis Lesions in Comparison With Uninvolved Skin.
    J Dermatol. 2025 Aug 6. doi: 10.1111/1346-8138.17824.
    PubMed         Abstract available
    
    
35. NOGAMI K, Nishikawa Y, Mochida K, Terada T, et al
    Maximum Standard Uptake Value of Pre-Therapeutic (18)F-Fluorodeoxyglucose Positron Emission Tomography Predicts Outcomes in Indolent Adult T-Cell Leukemia/Lymphoma Patients With Cutaneous Involvement.
    J Dermatol. 2025 Aug 6. doi: 10.1111/1346-8138.17867.
    PubMed         Abstract available
    
    
36. AZUMA S, Inaba Y, Tateishi C, Hashimoto T, et al
    A Case of Granular C3 Dermatosis With Methemoglobinemia After Administration of Dapsone.
    J Dermatol. 2025 Aug 5. doi: 10.1111/1346-8138.17887.
    PubMed        
    
    
37. MATSUO M, Takagi H, Iwata H
    A Case of Atopic Dermatitis Accompanied by Prurigo Nodularis Developed Eosinophilic Pneumonia on Dupilumab Therapy.
    J Dermatol. 2025 Aug 5. doi: 10.1111/1346-8138.17892.
    PubMed        
    
    
38. ZHU K, Lu Z, Cao L, Wu P, et al
    Relationships Between Secukinumab Concentrations, Disease Activity, and IL-17A Levels in Psoriasis: A Cross-Sectional Observational Study.
    J Dermatol. 2025 Aug 5. doi: 10.1111/1346-8138.17893.
    PubMed         Abstract available
    
    

    
    J Invest Dermatol

39. VAN DEN HURK K, Lommen K, Coussement L, van den Kerkhof D, et al
    Comprehensive analysis of the melanoma DNA methylome identifies Lymphocyte Antigen 75 (LY75) methylation as an independent marker predicting poor clinical outcome.
    J Invest Dermatol. 2025 Jul 30:S0022-202X(25)02311.
    PubMed         Abstract available
    
    
40. CHHABRA G, Su S, Shirley CA, Thornton J, et al
    A melanoma-specific gene network analysis identifies MZB1 (marginal zone B and B1 cell-specific protein) as a potential tumor promoter.
    J Invest Dermatol. 2025 Jul 30:S0022-202X(25)02310.
    PubMed         Abstract available
    
    
41. REZNIK AS, Vats K, Singh K, Mizes A, et al
    Emerging Roles of Ferroptosis in Skin Pathophysiology.
    J Invest Dermatol. 2025 Aug 4:S0022-202X(25)01850.
    PubMed         Abstract available
    
    
42. PUIG L
    Repurposing Roflumilast and the Emerging Landscape of Phosphodiesterase 4 Inhibition in Psoriasis.
    J Invest Dermatol. 2025 Aug 4:S0022-202X(25)01857.
    PubMed        
    
    
43. KITTLER H
    Artificial Intelligence and Skin Disease Scoring: An Opportunity to Reset the Standards.
    J Invest Dermatol. 2025 Aug 4:S0022-202X(25)02269.
    PubMed        
    
    
44. BUNICK CG
    Biologic Therapies Targeting Type 2 Signaling in Atopic Dermatitis: A Comparative Review of Structural and Thermodynamic Differences in Mechanism of Action.
    J Invest Dermatol. 2025 Aug 5:S0022-202X(25)02203.
    PubMed         Abstract available
    
    
45. ABBAS AA, Dlova N, Higgins CA
    Beyond the Skin Surface: Melanocyte Biology and the Spectrum of Health Inequities.
    J Invest Dermatol. 2025 Aug 8:S0022-202X(25)02251.
    PubMed         Abstract available
    
    

    
    Lancet

46. BRAIN E, Mir O, Bourbouloux E, Rigal O, et al
    Adjuvant chemotherapy and hormonotherapy versus adjuvant hormonotherapy alone for women aged 70 years and older with high-risk breast cancer based on the genomic grade index (ASTER 70s): a randomised phase 3 trial.
    Lancet. 2025;406:489-500.
    PubMed         Abstract available
    
    

    
    N Engl J Med

47. CAMPONE M, De Laurentiis M, Jhaveri K, Hu X, et al
    Vepdegestrant, a PROTAC Estrogen Receptor Degrader, in Advanced Breast Cancer.
    N Engl J Med. 2025 May 31. doi: 10.1056/NEJMoa2505725.
    PubMed         Abstract available
    
    
48. BIDARD FC, Mayer EL, Park YH, Janni W, et al
    First-Line Camizestrant for Emerging ESR1-Mutated Advanced Breast Cancer.
    N Engl J Med. 2025 Jun 1. doi: 10.1056/NEJMoa2502929.
    PubMed         Abstract available
    
    

    
    PLoS One

49. DANIELS J, Kyei KA, Walubo R, Nyantakyi AY, et al
    Prevalence and clinicopathological characteristics of breast cancer patients with brain metastases in Ghana: A single-center cross-sectional study.
    PLoS One. 2025;20:e0329308.
    PubMed         Abstract available
    
    
50. HELU A, Samawi H
    Assessing uncertainty: A study of entropy measures for Burr XII distribution under progressive Type-II censoring.
    PLoS One. 2025;20:e0329086.
    PubMed         Abstract available
    
    
51. AGIDE FD, Garmaroudi G, Sadeghi R, Shakibazadeh E, et al
    Designing and evaluation of the effect of community-based intervention on breast self-examination among reproductive-aged women in Ethiopia: A Cluster Randomized Controlled Trial.
    PLoS One. 2025;20:e0329839.
    PubMed         Abstract available
    
    
52. LU X, Wei C, Li C, Liu J, et al
    Do skin bacteriostatic agents reduce acute radiodermatitis in breast cancer patients? A prospective interventional study.
    PLoS One. 2025;20:e0328536.
    PubMed         Abstract available
    
    
53. TSAI MH, Vo JB, Moore JX, Ramin C, et al
    Mediating effects of mental and physical health on the association between chronic disease conditions and colorectal cancer screening utilization among breast cancer survivors.
    PLoS One. 2025;20:e0328353.
    PubMed         Abstract available
    
    
54. YANG C, Liu Y, Gai L, Zhang Z, et al
    Artesunate regulates malignant progression of breast cancer cells via lncRNA TUG1/miR-145-5p/HOXA5 axis.
    PLoS One. 2025;20:e0329490.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

55. VUILLE JA, Tanriover C, Antmen E, Micalizzi DS, et al
    The E3 ligase HECTD4 regulates COX-2-dependent tumor progression and metastasis.
    Proc Natl Acad Sci U S A. 2025;122:e2425621122.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Dermatology is free of charge.